-
Italian police recover stolen Renoir, Cezanne and Matisse worth 9 mn euros
-
Stocks tread water with eyes on oil price
-
Prize money 'critical' for athletics, says Coe
-
US retail sales weakest in over a year in July
-
WHO decries lack of justice over 10,000 attacks on health care
-
Israel calls for police to replace military in handling West Bank settlers
-
SNC SCANDIC PAY: Betala – över hela världen och utan gränser
-
स्कैंडिक पे: दुनिया में कहीं भी, बिना किसी सीमा के भुगतान करें।
-
SNC SCANDIC ÍOC: Íoc in áit ar bith ar domhan, gan teorainn
-
SNC SCANDIC PAY: Platby po celém světě bez omezení
-
SNC SCANDIC PAY: Płatności na całym świecie bez ograniczeń
-
SNCスカンディックペイ):世界中で、制限なくお支払いいただけます
-
SNC 스칸딕 페이: 전 세계 어디서나, 제한 없이 결제하세요
-
斯堪迪克支付:全球無界支付
-
SNC SCANDIC PAY: الدفع في جميع أنحاء العالم ودون حدود
-
СНК СКАНДІК ПЕЙ: Оплата по всьому світу без обмежень
-
СНК Скандик Пэй: Оплата по всему миру без границ
-
SNC SCANDIC PAY: Pay anywhere in the world, without limits
-
Europe wildfires: latest developments
-
Maresca uncertain over Rodri's future at Man City
-
Hotter Europe isn't cooling investor fervor for stocks
-
MEXC's August 2026 Proof of Reserves Confirms User Assets Fully Backed as Reserve Ratios Remain Above 100%
-
Duplantis into pole vault final at Euros
-
Zambia suspends vote counting nationwide citing violence
-
Maresca says 'anything can happen' amid talk of Rodri move to Barcelona
-
Coe pledges court showing to defend World Athletics over Russia stance
-
Indonesian leader vows to shut over 750 'unproductive' state-owned firms
-
Stocks mixed as oil climbs, dollar drops
-
NATO jets shoot down drone in Latvian airspace: spokesperson
-
Tourists beat the heat with 'magical' Colosseum night tours
-
Wildfire forces hundreds to flee in western Germany
-
Spain extends largest nuclear plant in policy U-turn
-
Croatian wildfire forces thousands to flee, injures dozens
-
Gill says 'huge honour' to lead India in 600th Test
-
Latest developments: Europe battles wildfires
-
Brazilian police recover Matisse works stolen in 2025
-
Is a new conflict brewing in northern Ethiopia?
-
Exiled Putin critic says push for peace put him in danger
-
UK firefighters 'under pressure' as multiple blazes rage
-
EU to study potential vaccine for Lyme disease: companies
-
ARKBRIDGE Reaches 50,000 Clients and Launches New Referral Rewards Program
-
Colombia vows to find all missing quake victims as rescue hopes fade
-
New wildfire forces evacuation of 500 people in France
-
Farage wins UK by-election as Count Binface claims 'moral victory'
-
ट्रोजन: एक अधिक खतरनाक राजनीतिक युग के लिए विशेष सुरक्षा
-
TROJAN: 더욱 위험해진 정치 시기를 위한 특별 보호 조치
-
《特洛伊木馬》:在政治局勢日趨險惡的時代,提供特別保護
-
『TROJAN』:政治情勢がより危険になる時代に向けた特別な保護策
-
TROJAN: Special protection for a more perilous political era
-
TROJAN: спеціальний захист для більш небезпечних політичних часів
Warmer noses are better at fighting colds: study
Chilly weather and common respiratory infections often go hand in hand.
Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.
Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.
These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.
The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.
"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.
For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?
To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.
They found it did in fact produce EVs that target viruses.
In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.
These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.
Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.
But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.
"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.
"This is the first quantitative and biologically plausible explanation that has been developed."
One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.
"That's an area of great interest for us and we certainly continue to pursue that," he said.
C.Hamad--SF-PST